IBERSOL SGPS SA (IBS.LS) Stock Fundamental Analysis
Europe - ELI:IBS - PTIBS0AM0008 - Common Stock
10.15 EUR
+0.05 (+0.5%)
Taking everything into account, IBS scores 4 out of 10 in our fundamental rating. IBS was compared to 54 industry peers in the Hotels, Restaurants & Leisure industry. IBS has an average financial health and profitability rating. While showing a medium growth rate, IBS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
IBS had positive earnings in the past year.
In the past year IBS had a positive cash flow from operations.
IBS had positive earnings in 4 of the past 5 years.
In the past 5 years IBS always reported a positive cash flow from operatings.
1.2 Ratios
IBS has a Return On Assets (1.51%) which is in line with its industry peers.
IBS has a Return On Equity of 3.42%. This is comparable to the rest of the industry: IBS outperforms 59.26% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.81%, IBS is in line with its industry, outperforming 46.30% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IBS is significantly below the industry average of 11.50%.
The last Return On Invested Capital (3.81%) for IBS is above the 3 year average (3.32%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROIC | 3.81% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.07%, IBS is in line with its industry, outperforming 46.30% of the companies in the same industry.
IBS's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 5.03%, IBS perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
In the last couple of years the Operating Margin of IBS has declined.
IBS has a Gross Margin (50.98%) which is in line with its industry peers.
IBS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% |
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IBS is destroying value.
The number of shares outstanding for IBS has been reduced compared to 1 year ago.
The number of shares outstanding for IBS has been increased compared to 5 years ago.
IBS has a worse debt/assets ratio than last year.
2.2 Solvency
IBS has an Altman-Z score of 2.01. This is not the best score and indicates that IBS is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.01, IBS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of IBS is 4.26, which is a neutral value as it means it would take IBS, 4.26 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.26, IBS is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that IBS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.71, IBS is doing good in the industry, outperforming 70.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.61
WACC6.22%
2.3 Liquidity
A Current Ratio of 0.96 indicates that IBS may have some problems paying its short term obligations.
IBS has a Current ratio (0.96) which is comparable to the rest of the industry.
IBS has a Quick Ratio of 0.96. This is a bad value and indicates that IBS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.87, IBS perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for IBS have decreased strongly by -30.51% in the last year.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
IBS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.65%.
The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
3.2 Future
Based on estimates for the next years, IBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.20% on average per year.
Based on estimates for the next years, IBS will show a small growth in Revenue. The Revenue will grow by 6.77% on average per year.
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 39.04, IBS can be considered very expensive at the moment.
IBS's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of IBS to the average of the S&P500 Index (25.83), we can say IBS is valued expensively.
With a Price/Forward Earnings ratio of 23.79, IBS is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as IBS.
IBS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.04 | ||
| Fwd PE | 23.79 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, IBS is valued a bit cheaper than the industry average as 79.63% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.95 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as IBS's earnings are expected to grow with 20.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.36%
EPS Next 3Y20.34%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.93%, IBS is a good candidate for dividend investing.
IBS's Dividend Yield is rather good when compared to the industry average which is at 3.15. IBS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, IBS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.93% |
5.2 History
On average, the dividend of IBS grows each year by 48.65%, which is quite nice.
Dividend Growth(5Y)48.65%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
268.99% of the earnings are spent on dividend by IBS. This is not a sustainable payout ratio.
IBS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP268.99%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
ELI:IBS (11/7/2025, 7:00:00 PM)
10.15
+0.05 (+0.5%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners21.88%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap421.33M
Revenue(TTM)511.65M
Net Income(TTM)10.61M
Analysts83.33
Price Target11.82 (16.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.93% |
Yearly Dividend0.49
Dividend Growth(5Y)48.65%
DP268.99%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)11.28%
Revenue beat(4)3
Avg Revenue beat(4)8.29%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)12.41%
Revenue beat(8)7
Avg Revenue beat(8)6.42%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-36.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.04 | ||
| Fwd PE | 23.79 | ||
| P/S | 0.82 | ||
| P/FCF | 5.95 | ||
| P/OCF | 3.61 | ||
| P/B | 1.36 | ||
| P/tB | 1.99 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY2.56%
EPS(NY)0.43
Fwd EY4.2%
FCF(TTM)1.71
FCFY16.82%
OCF(TTM)2.81
OCFY27.67%
SpS12.33
BVpS7.47
TBVpS5.09
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.51% | ||
| ROE | 3.42% | ||
| ROCE | 4.85% | ||
| ROIC | 3.81% | ||
| ROICexc | 4.93% | ||
| ROICexgc | 6.48% | ||
| OM | 5.03% | ||
| PM (TTM) | 2.07% | ||
| GM | 50.98% | ||
| FCFM | 13.85% |
ROA(3y)9.49%
ROA(5y)5.17%
ROE(3y)16.68%
ROE(5y)5.68%
ROIC(3y)3.32%
ROIC(5y)N/A
ROICexc(3y)5.24%
ROICexc(5y)N/A
ROICexgc(3y)7.05%
ROICexgc(5y)N/A
ROCE(3y)4.21%
ROCE(5y)N/A
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-3.32%
ROICexc growth 3Y-22.88%
ROICexc growth 5Y-3.24%
OM growth 3Y-40.02%
OM growth 5Y-6.76%
PM growth 3Y-42.54%
PM growth 5Y-4.22%
GM growth 3Y-0.29%
GM growth 5Y-0.28%
F-Score6
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 8.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 667.98% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 2.01 |
F-Score6
WACC6.22%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)9.76%
Cap/Sales(5y)11.65%
Profit Quality(3y)200.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.51%
EPS 3Y-29.2%
EPS 5Y-8.23%
EPS Q2Q%100%
EPS Next Y-16.54%
EPS Next 2Y15.36%
EPS Next 3Y20.34%
EPS Next 5Y18.2%
Revenue 1Y (TTM)17.65%
Revenue growth 3Y32.48%
Revenue growth 5Y-0.46%
Sales Q2Q%18.09%
Revenue Next Year15.39%
Revenue Next 2Y9.99%
Revenue Next 3Y8.52%
Revenue Next 5Y6.77%
EBIT growth 1Y19.24%
EBIT growth 3Y-20.54%
EBIT growth 5Y-7.19%
EBIT Next Year434.69%
EBIT Next 3Y84.16%
EBIT Next 5Y57.33%
FCF growth 1Y26.38%
FCF growth 3Y-0.14%
FCF growth 5Y-9.32%
OCF growth 1Y23.94%
OCF growth 3Y1.82%
OCF growth 5Y-6.35%
IBERSOL SGPS SA / IBS.LS FAQ
What is the ChartMill fundamental rating of IBERSOL SGPS SA (IBS.LS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to IBS.LS.
What is the valuation status for IBS stock?
ChartMill assigns a valuation rating of 3 / 10 to IBERSOL SGPS SA (IBS.LS). This can be considered as Overvalued.
Can you provide the profitability details for IBERSOL SGPS SA?
IBERSOL SGPS SA (IBS.LS) has a profitability rating of 4 / 10.
Can you provide the financial health for IBS stock?
The financial health rating of IBERSOL SGPS SA (IBS.LS) is 4 / 10.
What is the earnings growth outlook for IBERSOL SGPS SA?
The Earnings per Share (EPS) of IBERSOL SGPS SA (IBS.LS) is expected to decline by -16.54% in the next year.